 | • レポートコード：QYR2104Z0295 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、アムホテリシンBのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静滴、噴霧吸入、局所病変注入、その他）、用途別市場規模（膣炎、カンジダ感染症、リーシュマニア症、カラアザール、クリプトコッカス感染症、アスペルギルス感染症、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・アムホテリシンBの市場動向 ・企業の競争状況、市場シェア ・アムホテリシンBの種類別市場規模（静滴、噴霧吸入、局所病変注入、その他） ・アムホテリシンBの用途別市場規模（膣炎、カンジダ感染症、リーシュマニア症、カラアザール、クリプトコッカス感染症、アスペルギルス感染症、その他） ・アムホテリシンBの北米市場規模2016-2027（アメリカ、カナダ） ・アムホテリシンBのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・アムホテリシンBのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アムホテリシンBの中南米市場規模2016-2027（メキシコ、ブラジル） ・アムホテリシンBの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、Matinas BioPharma、Nanox、Nanomerics、DNDi、Abzena、Bharat Serums、Jina Pharma、Astellas Pharma、Leadiant Biosciences、Kadmon Corporation (Eli Lilly and Company)、InterMune、Sterimax Inc、X-GEN Pharmaceuticals） ・結論 |
Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.
Market Analysis and Insights: Global Amphotericin B Market
The global Amphotericin B market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Amphotericin B market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Amphotericin B market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Amphotericin B market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Amphotericin B market.
Global Amphotericin B Scope and Market Size
Amphotericin B market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amphotericin B market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Static Drops
Atomization Inhalation
Local Lesion Injection
Other
Segment by Application
Vaginitis
Candida Infection
Leishmaniasis
Kala-Azar
Cryptococcal Infection
Aspergillus Infection
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol-Myers Squibb
Matinas BioPharma
Nanox
Nanomerics
DNDi
Abzena
Bharat Serums
Jina Pharma
Astellas Pharma
Leadiant Biosciences
Kadmon Corporation (Eli Lilly and Company)
InterMune
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amphotericin B Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Static Drops
1.2.3 Atomization Inhalation
1.2.4 Local Lesion Injection
1.2.5 Other
1.3 Market by Application
1.3.1 Global Amphotericin B Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Vaginitis
1.3.3 Candida Infection
1.3.4 Leishmaniasis
1.3.5 Kala-Azar
1.3.6 Cryptococcal Infection
1.3.7 Aspergillus Infection
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Amphotericin B Market Perspective (2016-2027)
2.2 Amphotericin B Growth Trends by Regions
2.2.1 Amphotericin B Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Amphotericin B Historic Market Share by Regions (2016-2021)
2.2.3 Amphotericin B Forecasted Market Size by Regions (2022-2027)
2.3 Amphotericin B Industry Dynamic
2.3.1 Amphotericin B Market Trends
2.3.2 Amphotericin B Market Drivers
2.3.3 Amphotericin B Market Challenges
2.3.4 Amphotericin B Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Amphotericin B Players by Revenue
3.1.1 Global Top Amphotericin B Players by Revenue (2016-2021)
3.1.2 Global Amphotericin B Revenue Market Share by Players (2016-2021)
3.2 Global Amphotericin B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Amphotericin B Revenue
3.4 Global Amphotericin B Market Concentration Ratio
3.4.1 Global Amphotericin B Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amphotericin B Revenue in 2020
3.5 Amphotericin B Key Players Head office and Area Served
3.6 Key Players Amphotericin B Product Solution and Service
3.7 Date of Enter into Amphotericin B Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Amphotericin B Breakdown Data by Type
4.1 Global Amphotericin B Historic Market Size by Type (2016-2021)
4.2 Global Amphotericin B Forecasted Market Size by Type (2022-2027)
5 Amphotericin B Breakdown Data by Application
5.1 Global Amphotericin B Historic Market Size by Application (2016-2021)
5.2 Global Amphotericin B Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Amphotericin B Market Size (2016-2027)
6.2 North America Amphotericin B Market Size by Type
6.2.1 North America Amphotericin B Market Size by Type (2016-2021)
6.2.2 North America Amphotericin B Market Size by Type (2022-2027)
6.2.3 North America Amphotericin B Market Size by Type (2016-2027)
6.3 North America Amphotericin B Market Size by Application
6.3.1 North America Amphotericin B Market Size by Application (2016-2021)
6.3.2 North America Amphotericin B Market Size by Application (2022-2027)
6.3.3 North America Amphotericin B Market Size by Application (2016-2027)
6.4 North America Amphotericin B Market Size by Country
6.4.1 North America Amphotericin B Market Size by Country (2016-2021)
6.4.2 North America Amphotericin B Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Amphotericin B Market Size (2016-2027)
7.2 Europe Amphotericin B Market Size by Type
7.2.1 Europe Amphotericin B Market Size by Type (2016-2021)
7.2.2 Europe Amphotericin B Market Size by Type (2022-2027)
7.2.3 Europe Amphotericin B Market Size by Type (2016-2027)
7.3 Europe Amphotericin B Market Size by Application
7.3.1 Europe Amphotericin B Market Size by Application (2016-2021)
7.3.2 Europe Amphotericin B Market Size by Application (2022-2027)
7.3.3 Europe Amphotericin B Market Size by Application (2016-2027)
7.4 Europe Amphotericin B Market Size by Country
7.4.1 Europe Amphotericin B Market Size by Country (2016-2021)
7.4.2 Europe Amphotericin B Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Amphotericin B Market Size (2016-2027)
8.2 Asia-Pacific Amphotericin B Market Size by Type
8.2.1 Asia-Pacific Amphotericin B Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Amphotericin B Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Amphotericin B Market Size by Type (2016-2027)
8.3 Asia-Pacific Amphotericin B Market Size by Application
8.3.1 Asia-Pacific Amphotericin B Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Amphotericin B Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Amphotericin B Market Size by Application (2016-2027)
8.4 Asia-Pacific Amphotericin B Market Size by Region
8.4.1 Asia-Pacific Amphotericin B Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Amphotericin B Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Amphotericin B Market Size (2016-2027)
9.2 Latin America Amphotericin B Market Size by Type
9.2.1 Latin America Amphotericin B Market Size by Type (2016-2021)
9.2.2 Latin America Amphotericin B Market Size by Type (2022-2027)
9.2.3 Latin America Amphotericin B Market Size by Type (2016-2027)
9.3 Latin America Amphotericin B Market Size by Application
9.3.1 Latin America Amphotericin B Market Size by Application (2016-2021)
9.3.2 Latin America Amphotericin B Market Size by Application (2022-2027)
9.3.3 Latin America Amphotericin B Market Size by Application (2016-2027)
9.4 Latin America Amphotericin B Market Size by Country
9.4.1 Latin America Amphotericin B Market Size by Country (2016-2021)
9.4.2 Latin America Amphotericin B Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Amphotericin B Market Size (2016-2027)
10.2 Middle East & Africa Amphotericin B Market Size by Type
10.2.1 Middle East & Africa Amphotericin B Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Amphotericin B Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Amphotericin B Market Size by Type (2016-2027)
10.3 Middle East & Africa Amphotericin B Market Size by Application
10.3.1 Middle East & Africa Amphotericin B Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Amphotericin B Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Amphotericin B Market Size by Application (2016-2027)
10.4 Middle East & Africa Amphotericin B Market Size by Country
10.4.1 Middle East & Africa Amphotericin B Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Amphotericin B Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Amphotericin B Introduction
11.1.4 Bristol-Myers Squibb Revenue in Amphotericin B Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Matinas BioPharma
11.2.1 Matinas BioPharma Company Details
11.2.2 Matinas BioPharma Business Overview
11.2.3 Matinas BioPharma Amphotericin B Introduction
11.2.4 Matinas BioPharma Revenue in Amphotericin B Business (2016-2021)
11.2.5 Matinas BioPharma Recent Development
11.3 Nanox
11.3.1 Nanox Company Details
11.3.2 Nanox Business Overview
11.3.3 Nanox Amphotericin B Introduction
11.3.4 Nanox Revenue in Amphotericin B Business (2016-2021)
11.3.5 Nanox Recent Development
11.4 Nanomerics
11.4.1 Nanomerics Company Details
11.4.2 Nanomerics Business Overview
11.4.3 Nanomerics Amphotericin B Introduction
11.4.4 Nanomerics Revenue in Amphotericin B Business (2016-2021)
11.4.5 Nanomerics Recent Development
11.5 DNDi
11.5.1 DNDi Company Details
11.5.2 DNDi Business Overview
11.5.3 DNDi Amphotericin B Introduction
11.5.4 DNDi Revenue in Amphotericin B Business (2016-2021)
11.5.5 DNDi Recent Development
11.6 Abzena
11.6.1 Abzena Company Details
11.6.2 Abzena Business Overview
11.6.3 Abzena Amphotericin B Introduction
11.6.4 Abzena Revenue in Amphotericin B Business (2016-2021)
11.6.5 Abzena Recent Development
11.7 Bharat Serums
11.7.1 Bharat Serums Company Details
11.7.2 Bharat Serums Business Overview
11.7.3 Bharat Serums Amphotericin B Introduction
11.7.4 Bharat Serums Revenue in Amphotericin B Business (2016-2021)
11.7.5 Bharat Serums Recent Development
11.8 Jina Pharma
11.8.1 Jina Pharma Company Details
11.8.2 Jina Pharma Business Overview
11.8.3 Jina Pharma Amphotericin B Introduction
11.8.4 Jina Pharma Revenue in Amphotericin B Business (2016-2021)
11.8.5 Jina Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Amphotericin B Introduction
11.9.4 Astellas Pharma Revenue in Amphotericin B Business (2016-2021)
11.9.5 Astellas Pharma Recent Development
11.10 Leadiant Biosciences
11.10.1 Leadiant Biosciences Company Details
11.10.2 Leadiant Biosciences Business Overview
11.10.3 Leadiant Biosciences Amphotericin B Introduction
11.10.4 Leadiant Biosciences Revenue in Amphotericin B Business (2016-2021)
11.10.5 Leadiant Biosciences Recent Development
11.11 Kadmon Corporation (Eli Lilly and Company)
11.11.1 Kadmon Corporation (Eli Lilly and Company) Company Details
11.11.2 Kadmon Corporation (Eli Lilly and Company) Business Overview
11.11.3 Kadmon Corporation (Eli Lilly and Company) Amphotericin B Introduction
11.11.4 Kadmon Corporation (Eli Lilly and Company) Revenue in Amphotericin B Business (2016-2021)
11.11.5 Kadmon Corporation (Eli Lilly and Company) Recent Development
11.12 InterMune
11.12.1 InterMune Company Details
11.12.2 InterMune Business Overview
11.12.3 InterMune Amphotericin B Introduction
11.12.4 InterMune Revenue in Amphotericin B Business (2016-2021)
11.12.5 InterMune Recent Development
11.13 Sterimax Inc
11.13.1 Sterimax Inc Company Details
11.13.2 Sterimax Inc Business Overview
11.13.3 Sterimax Inc Amphotericin B Introduction
11.13.4 Sterimax Inc Revenue in Amphotericin B Business (2016-2021)
11.13.5 Sterimax Inc Recent Development
11.14 X-GEN Pharmaceuticals
11.14.1 X-GEN Pharmaceuticals Company Details
11.14.2 X-GEN Pharmaceuticals Business Overview
11.14.3 X-GEN Pharmaceuticals Amphotericin B Introduction
11.14.4 X-GEN Pharmaceuticals Revenue in Amphotericin B Business (2016-2021)
11.14.5 X-GEN Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Amphotericin B Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Static Drops
Table 3. Key Players of Atomization Inhalation
Table 4. Key Players of Local Lesion Injection
Table 5. Key Players of Other
Table 6. Global Amphotericin B Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Amphotericin B Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Amphotericin B Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Amphotericin B Market Share by Regions (2016-2021)
Table 10. Global Amphotericin B Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Amphotericin B Market Share by Regions (2022-2027)
Table 12. Amphotericin B Market Trends
Table 13. Amphotericin B Market Drivers
Table 14. Amphotericin B Market Challenges
Table 15. Amphotericin B Market Restraints
Table 16. Global Amphotericin B Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Amphotericin B Market Share by Players (2016-2021)
Table 18. Global Top Amphotericin B Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amphotericin B as of 2020)
Table 19. Ranking of Global Top Amphotericin B Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Amphotericin B Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Amphotericin B Product Solution and Service
Table 23. Date of Enter into Amphotericin B Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Amphotericin B Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Amphotericin B Revenue Market Share by Type (2016-2021)
Table 27. Global Amphotericin B Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Amphotericin B Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Amphotericin B Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Amphotericin B Revenue Market Share by Application (2016-2021)
Table 31. Global Amphotericin B Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Amphotericin B Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Amphotericin B Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Amphotericin B Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Amphotericin B Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Amphotericin B Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Amphotericin B Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Amphotericin B Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Amphotericin B Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Amphotericin B Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Amphotericin B Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Amphotericin B Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Amphotericin B Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Amphotericin B Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Amphotericin B Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Amphotericin B Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Amphotericin B Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Amphotericin B Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Amphotericin B Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Amphotericin B Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Amphotericin B Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Amphotericin B Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Amphotericin B Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Amphotericin B Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Amphotericin B Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Amphotericin B Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Amphotericin B Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Amphotericin B Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Amphotericin B Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Amphotericin B Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Amphotericin B Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Amphotericin B Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bristol-Myers Squibb Company Details
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Amphotericin B Product
Table 66. Bristol-Myers Squibb Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Matinas BioPharma Company Details
Table 69. Matinas BioPharma Business Overview
Table 70. Matinas BioPharma Amphotericin B Product
Table 71. Matinas BioPharma Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 72. Matinas BioPharma Recent Development
Table 73. Nanox Company Details
Table 74. Nanox Business Overview
Table 75. Nanox Amphotericin B Product
Table 76. Nanox Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 77. Nanox Recent Development
Table 78. Nanomerics Company Details
Table 79. Nanomerics Business Overview
Table 80. Nanomerics Amphotericin B Product
Table 81. Nanomerics Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 82. Nanomerics Recent Development
Table 83. DNDi Company Details
Table 84. DNDi Business Overview
Table 85. DNDi Amphotericin B Product
Table 86. DNDi Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 87. DNDi Recent Development
Table 88. Abzena Company Details
Table 89. Abzena Business Overview
Table 90. Abzena Amphotericin B Product
Table 91. Abzena Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 92. Abzena Recent Development
Table 93. Bharat Serums Company Details
Table 94. Bharat Serums Business Overview
Table 95. Bharat Serums Amphotericin B Product
Table 96. Bharat Serums Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 97. Bharat Serums Recent Development
Table 98. Jina Pharma Company Details
Table 99. Jina Pharma Business Overview
Table 100. Jina Pharma Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 101. Jina Pharma Recent Development
Table 102. Astellas Pharma Company Details
Table 103. Astellas Pharma Business Overview
Table 104. Astellas Pharma Amphotericin B Product
Table 105. Astellas Pharma Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 106. Astellas Pharma Recent Development
Table 107. Leadiant Biosciences Company Details
Table 108. Leadiant Biosciences Business Overview
Table 109. Leadiant Biosciences Amphotericin B Product
Table 110. Leadiant Biosciences Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 111. Leadiant Biosciences Recent Development
Table 112. Kadmon Corporation (Eli Lilly and Company) Company Details
Table 113. Kadmon Corporation (Eli Lilly and Company) Business Overview
Table 114. Kadmon Corporation (Eli Lilly and Company) Amphotericin B Product
Table 115. Kadmon Corporation (Eli Lilly and Company) Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 116. Kadmon Corporation (Eli Lilly and Company) Recent Development
Table 117. InterMune Company Details
Table 118. InterMune Business Overview
Table 119. InterMune Amphotericin B Product
Table 120. InterMune Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 121. InterMune Recent Development
Table 122. Sterimax Inc Company Details
Table 123. Sterimax Inc Business Overview
Table 124. Sterimax Inc Amphotericin B Product
Table 125. Sterimax Inc Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 126. Sterimax Inc Recent Development
Table 127. X-GEN Pharmaceuticals Company Details
Table 128. X-GEN Pharmaceuticals Business Overview
Table 129. X-GEN Pharmaceuticals Amphotericin B Product
Table 130. X-GEN Pharmaceuticals Revenue in Amphotericin B Business (2016-2021) & (US$ Million)
Table 131. X-GEN Pharmaceuticals Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amphotericin B Market Share by Type: 2020 VS 2027
Figure 2. Static Drops Features
Figure 3. Atomization Inhalation Features
Figure 4. Local Lesion Injection Features
Figure 5. Other Features
Figure 6. Global Amphotericin B Market Share by Application: 2020 VS 2027
Figure 7. Vaginitis Case Studies
Figure 8. Candida Infection Case Studies
Figure 9. Leishmaniasis Case Studies
Figure 10. Kala-Azar Case Studies
Figure 11. Cryptococcal Infection Case Studies
Figure 12. Aspergillus Infection Case Studies
Figure 13. Other Case Studies
Figure 14. Amphotericin B Report Years Considered
Figure 15. Global Amphotericin B Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Amphotericin B Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Amphotericin B Market Share by Regions: 2020 VS 2027
Figure 18. Global Amphotericin B Market Share by Regions (2022-2027)
Figure 19. Global Amphotericin B Market Share by Players in 2020
Figure 20. Global Top Amphotericin B Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amphotericin B as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Amphotericin B Revenue in 2020
Figure 22. Global Amphotericin B Revenue Market Share by Type (2016-2021)
Figure 23. Global Amphotericin B Revenue Market Share by Type (2022-2027)
Figure 24. North America Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Amphotericin B Market Share by Type (2016-2027)
Figure 26. North America Amphotericin B Market Share by Application (2016-2027)
Figure 27. North America Amphotericin B Market Share by Country (2016-2027)
Figure 28. United States Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Amphotericin B Market Share by Type (2016-2027)
Figure 32. Europe Amphotericin B Market Share by Application (2016-2027)
Figure 33. Europe Amphotericin B Market Share by Country (2016-2027)
Figure 34. Germany Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Amphotericin B Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Amphotericin B Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Amphotericin B Market Share by Region (2016-2027)
Figure 44. China Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Amphotericin B Market Share by Type (2016-2027)
Figure 52. Latin America Amphotericin B Market Share by Application (2016-2027)
Figure 53. Latin America Amphotericin B Market Share by Country (2016-2027)
Figure 54. Mexico Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Amphotericin B Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Amphotericin B Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Amphotericin B Market Share by Country (2016-2027)
Figure 60. Turkey Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Amphotericin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 64. Matinas BioPharma Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 65. Nanox Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 66. Nanomerics Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 67. DNDi Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 68. Abzena Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 69. Bharat Serums Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 70. Jina Pharma Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 71. Astellas Pharma Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 72. Leadiant Biosciences Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 73. Kadmon Corporation (Eli Lilly and Company) Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 74. InterMune Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 75. Sterimax Inc Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 76. X-GEN Pharmaceuticals Revenue Growth Rate in Amphotericin B Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界のサイトメガロウイルス（CMV）感染市場規模・現状・予測（2021年-2027年） Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection c…- 世界の尿路感染症治療市場規模・現状・予測（2021年-2027年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 世界の血液感染検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blood Infection Testing Market The global Blood Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の菌血症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bloodstream Infection Testing Market The global Bloodstream Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界の耳感染症治療市場規模・現状・予測（2021年-2027年） An ear infection occurs due to invasion by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute but chronic ear infections can cause permanent damage to the middle and inner ear. Eustachian tubes, small tubes running from ear to the back of the th…